Solara Active Pharma Sciences Limited Cash Flow Conversion Efficiency
Solara Active Pharma Sciences Limited cash flow conversion efficiency. Based on the latest financial reports, Solara Active Pharma Sciences Limited (SOLARA) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs740.70 Million ≈ $8.01 Million USD) by net assets (Rs12.57 Billion ≈ $135.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Solara Active Pharma Sciences Limited (2017–2025)
Cash flow conversion efficiency of Solara Active Pharma Sciences Limited from 2017 to 2025. This chart illustrates how Solara Active Pharma Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SOLARA share price today for real-time trading data and today's change.
Solara Active Pharma Sciences Limited Cash Flow Conversion Ratio Explained
Solara Active Pharma Sciences Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Solara Active Pharma Sciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solara Active Pharma Sciences Limited ranked by their cash flow conversion efficiency. Also see Solara Active Pharma Sciences Limited (SOLARA) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bermaz Auto Bhd
KLSE:5248
|
-0.012x |
|
Cahya Mata Sarawak Bhd
KLSE:2852
|
0.027x |
|
Fifth Era Acquisition Corp I Class A Ordinary Shares
NASDAQ:FERA
|
-0.001x |
|
Kitex Garments Limited
NSE:KITEX
|
0.174x |
|
Hiron-Trade Investments & Industrial Buildings Ltd
TA:HRON
|
0.015x |
|
MAKUS Inc
KQ:093520
|
0.021x |
|
Webzen Inc
KQ:069080
|
0.009x |
|
Pacific Smiles Group Ltd
AU:PSQ
|
0.382x |
Annual Cash Flow Conversion Efficiency for Solara Active Pharma Sciences Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Solara Active Pharma Sciences Limited from 2017 to 2025. Review SOLARA FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs10.97 Billion ≈ $118.63 Million |
Rs2.13 Billion ≈ $23.02 Million |
0.194x | +66.91% |
| 2024-03-31 | Rs9.37 Billion ≈ $101.29 Million |
Rs1.09 Billion ≈ $11.77 Million |
0.116x | +11.78% |
| 2023-03-31 | Rs15.02 Billion ≈ $162.49 Million |
Rs1.56 Billion ≈ $16.90 Million |
0.104x | +165.95% |
| 2022-03-31 | Rs15.35 Billion ≈ $165.98 Million |
Rs-2.42 Billion ≈ $-26.17 Million |
-0.158x | -261.57% |
| 2021-03-31 | Rs15.93 Billion ≈ $172.25 Million |
Rs1.55 Billion ≈ $16.81 Million |
0.098x | -56.43% |
| 2020-03-31 | Rs10.90 Billion ≈ $117.90 Million |
Rs2.44 Billion ≈ $26.41 Million |
0.224x | +34.55% |
| 2019-03-31 | Rs9.60 Billion ≈ $103.85 Million |
Rs1.60 Billion ≈ $17.29 Million |
0.166x | +159.91% |
| 2018-03-31 | Rs7.68 Billion ≈ $83.11 Million |
Rs492.23 Million ≈ $5.32 Million |
0.064x | -100.00% |
| 2017-03-31 | Rs67.00K ≈ $724.58 |
Rs492.23 Million ≈ $5.32 Million |
7346.716x | -- |
About Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arr… Read more